Study design for restricted mean time analysis of recurrent events and death

On recurrent-event win ratio

(2022) Lu Mao et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Power and Sample Size Calculations for the Restricted Mean Time Analysis of Prioritized Composite Endpoints

(2022) Lu Mao   Statistics in Biopharmaceutical Research

A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies

(2022) Rachel Axelrod et al.   BIOMETRICS

An alternative formulation of Coxian phase‐type distributions with covariates: Application to emergency department length of stay

(2021) Jean Rizk et al.   STATISTICS IN MEDICINE

Estimands for recurrent event endpoints in the presence of a terminal event

(2021) Heinz Schmidli et al.   Statistics in Biopharmaceutical Research

Statistical models for composite endpoints of death and non-fatal events: a review

(2021) Lu Mao et al.   Statistics in Biopharmaceutical Research

Sample size calculation for recurrent event data with additive rates models

(2021) Liang Zhu et al.   PHARMACEUTICAL STATISTICS

Methodological challenges in the analysis of recurrent events for randomised controlled trials with application to cardiovascular events in LEADER

(2021) Julie Kjærulff Furberg et al.   PHARMACEUTICAL STATISTICS

On restricted mean time in favor of treatment

(2021) Lu Mao   BIOMETRICS

On the empirical choice of the time window for restricted mean survival time

(2020) Lu Tian et al.   BIOMETRICS

Subtleties in the interpretation of hazard contrasts

(2020) Torben Martinussen et al.   LIFETIME DATA ANALYSIS

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease

(2020) Orly Vardeny et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Adjusting win statistics for dependent censoring

(2020) Gaohong Dong et al.   PHARMACEUTICAL STATISTICS

Sample size calculation for the Andersen‐Gill model comparing rates of recurrent events

(2019) Yongqiang Tang et al.   STATISTICS IN MEDICINE

Sample size and power for the weighted log‐rank test and Kaplan‐Meier based tests with allowance for nonproportional hazards

(2019) Godwin Yung et al.   BIOMETRICS

Estimands and Their Role in Clinical Trials

(2017) Mouna Akacha et al.   Statistics in Biopharmaceutical Research

Semiparametric regression for the weighted composite endpoint of recurrent and terminal events

(2015) Lu Mao et al.   BIOSTATISTICS

Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer

(2015) J Péron et al.   BRITISH JOURNAL OF CANCER

Does Cox analysis of a randomized survival study yield a causal treatment effect?

(2015) Odd O. Aalen et al.   LIFETIME DATA ANALYSIS

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

(2014) Jennifer K. Rogers et al.   EUROPEAN JOURNAL OF HEART FAILURE

Sample Size Determination in Shared Frailty Models for Multivariate Time-to-Event Data

(2014) Liddy M. Chen et al.   Journal of Biopharmaceutical Statistics

Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials?

(2012) S. D. Anker et al.   EUROPEAN HEART JOURNAL

Sample size calculation for recurrent events data in one-arm studies

(2012) Paola Rebora et al.   PHARMACEUTICAL STATISTICS

The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

(2011) S. J. Pocock et al.   EUROPEAN HEART JOURNAL

The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt

(2011) Patrick Royston et al.   STATISTICS IN MEDICINE

Estimating treatment effects on the marginal recurrent event mean in the presence of a terminating event

(2010) Douglas E. Schaubel et al.   LIFETIME DATA ANALYSIS

Generalized pairwise comparisons of prioritized outcomes in the two-sample problem

(2010) Marc Buyse   STATISTICS IN MEDICINE

The Hazards of Hazard Ratios

(2009) Miguel A. Hernán   EPIDEMIOLOGY

Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure

(2009) Christopher M. O’Connor et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Semiparametric Transformation Models with Random Effects for Joint Analysis of Recurrent and Terminal Events

(2008) Donglin Zeng et al.   BIOMETRICS

Sample size formula for randomized controlled trials with counts of recurrent events

(2008) Toshiro Tango   STATISTICS & PROBABILITY LETTERS